نتائج البحث

Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy.

• Authors : Wang K; School of Life and Environmental Sciences, Shaoxing University, Shaoxing, 312000, Zhejiang, China.; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, 312000, Zhejiang, China.

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/chemistry ; Catechin*/Catechin*/Catechin*/analogs & derivatives

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Dec 24; Vol. 22 (1), pp. 793. Date of Electronic Publication: 2024 Dec 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

Exosomal miR-9-5p derived from iPSC-MSCs ameliorates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence.

• Authors : Zheng, Huifeng^1,2 (AUTHOR); Liang, Xiaoting^3,4 (AUTHOR); Liu, Baojuan¹ (AUTHOR)

• Source: Journal of Nanobiotechnology. 4/20/2024, Vol. 22 Issue 1, p1-19. 19p.

تفاصيل العنوان

Ultrasound targeted microbubble destruction assisted exosomal delivery of siHmox1 effectively inhibits doxorubicin-induced cardiomyocyte ferroptosis.

• Authors : Chen J; Department of Ultrasound Diagnostics, Tangdu Hospital, The Fourth Military Medical University, NO. 569th Xinsi Road, Xi'an, Shaanxi, 710038, People's Republic of China.; Department of Health Medicine, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Exosomes*/Exosomes*/Exosomes*/metabolism

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Sep 02; Vol. 22 (1), pp. 531. Date of Electronic Publication: 2024 Sep 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy against Breast Cancer and Attenuated Doxorubicin-Induced Cardiotoxicity.

• Authors : Geng, Siqi^1,2 (AUTHOR); Feng, Qiang² (AUTHOR); Wang, Chujie² (AUTHOR)

• Source: Journal of Nanobiotechnology. 9/21/2023, Vol. 21 Issue 1, p1-17. 17p.

تفاصيل العنوان

Momordica charantia L.-derived exosome-like nanovesicles stabilize p62 expression to ameliorate doxorubicin cardiotoxicity.

• Authors : Ye C; School of Medical Technology, Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou city, Jiangsu Province, 221004, PR China.; Yan C

Subjects: Doxorubicin* ; Cardiotoxicity*/Cardiotoxicity*/Cardiotoxicity*/prevention & control ; Cardiotoxicity*/Cardiotoxicity*/Cardiotoxicity*/metabolism

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Aug 02; Vol. 22 (1), pp. 464. Date of Electronic Publication: 2024 Aug 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3'-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer.

• Authors : Sarkar R; Department of Cancer Chemoprevention, Chittaranjan National Cancer Institute (CNCI), 37, S.P. Mukherjee Road, Kolkata, West Bengal, 700 026, India.; Biswas S

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology ; Epithelial-Mesenchymal Transition*/Epithelial-Mesenchymal Transition*/Epithelial-Mesenchymal Transition*/drug effects

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 25; Vol. 22 (1), pp. 285. Date of Electronic Publication: 2024 May 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.

• Authors : Sevieri, Marta¹ (AUTHOR); Andreata, Francesco² (AUTHOR); Mainini, Francesco¹ (AUTHOR)

• Source: Journal of Nanobiotechnology. 5/15/2024, Vol. 22 Issue 1, p1-16. 16p.

تفاصيل العنوان

Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy

• Authors : Jinseong Kim; Man Kyu Shim; Yujeong Moon

Subjects: Aposomes; Cancer immunotherapy; Cathepsin B

• Source: J NanobiotechnologyJournal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-19 (2024)

تفاصيل العنوان

Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy.

• Authors : Lee, Yeeun¹ (AUTHOR); Lee, Donghyun¹ (AUTHOR); Park, Eunyoung¹ (AUTHOR)

• Source: Journal of Nanobiotechnology. 12/7/2021, Vol. 19 Issue 1, p1-13. 13p.

تفاصيل العنوان

Tumor microenvironment responsive nano-herb and CRISPR delivery system for synergistic chemotherapy and immunotherapy.

• Authors : Jia, Yuanyuan¹ (AUTHOR); Yao, Yuhui² (AUTHOR); Fan, Lingyao² (AUTHOR)

• Source: Journal of Nanobiotechnology. 6/19/2024, Vol. 22 Issue 1, p1-16. 16p.

تفاصيل العنوان